422 related articles for article (PubMed ID: 11312622)
21. In utero nucleoside reverse transcriptase inhibitor exposure and signs of possible mitochondrial dysfunction in HIV-uninfected children.
Brogly SB; Ylitalo N; Mofenson LM; Oleske J; Van Dyke R; Crain MJ; Abzug MJ; Brady M; Jean-Philippe P; Hughes MD; Seage GR
AIDS; 2007 May; 21(8):929-38. PubMed ID: 17457086
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of mother-to-infant HIV transmission in tribal women from India.
Kumar RM; Uduman SA; Khurranna AK
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jul; 9(3):238-42. PubMed ID: 7788422
[TBL] [Abstract][Full Text] [Related]
23. Missed opportunities for perinatal HIV prevention among HIV-exposed infants born 1996-2000, pediatric spectrum of HIV disease cohort.
Peters V; Liu KL; Dominguez K; Frederick T; Melville S; Hsu HW; Ortiz I; Rakusan T; Gill B; Thomas P
Pediatrics; 2003 May; 111(5 Pt 2):1186-91. PubMed ID: 12728136
[TBL] [Abstract][Full Text] [Related]
24. Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy.
Taha TE; Kumwenda J; Cole SR; Hoover DR; Kafulafula G; Fowler MG; Thigpen MC; Li Q; Kumwenda NI; Mofenson L
J Infect Dis; 2009 Nov; 200(10):1490-7. PubMed ID: 19832114
[TBL] [Abstract][Full Text] [Related]
25. Hematological effects of zidovudine prophylaxis in newborn infants with and without prenatal exposure to zidovudine.
Baroncelli S; Pinnetti C; Genovese O; Tamburrini E; Floridia M
J Med Virol; 2011 Mar; 83(3):551-6. PubMed ID: 21264878
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of zidovudine and human immunodeficiency virus (HIV) hyperimmune immunoglobulin for reducing perinatal HIV transmission from HIV-infected women with advanced disease: results of Pediatric AIDS Clinical Trials Group protocol 185.
Stiehm ER; Lambert JS; Mofenson LM; Bethel J; Whitehouse J; Nugent R; Moye J; Glenn Fowler M; Mathieson BJ; Reichelderfer P; Nemo GJ; Korelitz J; Meyer WA; Sapan CV; Jimenez E; Gandia J; Scott G; O'Sullivan MJ; Kovacs A; Stek A; Shearer WT; Hammill H
J Infect Dis; 1999 Mar; 179(3):567-75. PubMed ID: 9952362
[TBL] [Abstract][Full Text] [Related]
27. Genotypic resistance tests for the management of the HIV-infected pregnant woman.
Bassetti D; Cargnel A
Scand J Infect Dis Suppl; 2003; 106():70-4. PubMed ID: 15000589
[TBL] [Abstract][Full Text] [Related]
28. Mother-to-child HIV transmission in a cohort of pregnant women diagnosed by rapid HIV testing at Tijuana General Hospital, Baja California, Mexico.
Viani RM; Ruiz-Calderon J; Lopez G; Chacón-Cruz E; Spector SA
J Int Assoc Physicians AIDS Care (Chic); 2010; 9(2):82-6. PubMed ID: 20335496
[TBL] [Abstract][Full Text] [Related]
29. Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?
Briand N; Warszawski J; Mandelbrot L; Dollfus C; Pannier E; Cravello L; Nguyen R; Matheron I; Winer N; Tubiana R; Rouzioux C; Faye A; Blanche S;
Clin Infect Dis; 2013 Sep; 57(6):903-14. PubMed ID: 23728147
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with zidovudine receipt and prenatal care among HIV-infected pregnant women in New Jersey.
Abatemarco DJ; Catov JM; Cross H; Delnevo C; Hausman A
J Health Care Poor Underserved; 2008 Aug; 19(3):814-28. PubMed ID: 18677072
[TBL] [Abstract][Full Text] [Related]
31. Cost-effectiveness of interventions to reduce vertical HIV transmission from pregnant women who have not received prenatal care.
Mrus JM; Tsevat J
Med Decis Making; 2004; 24(1):30-9. PubMed ID: 15005952
[TBL] [Abstract][Full Text] [Related]
32. HIV testing and prophylaxis to prevent mother-to-child transmission in the United States.
American Academy of Pediatrics Committee on Pediatric AIDS
Pediatrics; 2008 Nov; 122(5):1127-34. PubMed ID: 18977995
[TBL] [Abstract][Full Text] [Related]
33. [Mode of delivery of HIV-infected women: a retrospective study of 358 pregnancies followed in the same hospital between 2000 and 2004].
Rodrigues A; Faucher P; Batallan A; Allal L; Legac S; Matheron S; Madelenat P
Gynecol Obstet Fertil; 2006 Apr; 34(4):304-11. PubMed ID: 16574463
[TBL] [Abstract][Full Text] [Related]
34. Nevirapine and zidovudine at birth to reduce perinatal transmission of HIV in an African setting: a randomized controlled trial.
Taha TE; Kumwenda NI; Hoover DR; Fiscus SA; Kafulafula G; Nkhoma C; Nour S; Chen S; Liomba G; Miotti PG; Broadhead RL
JAMA; 2004 Jul; 292(2):202-9. PubMed ID: 15249569
[TBL] [Abstract][Full Text] [Related]
35. German-Austrian recommendations for HIV-therapy in pregnancy--common declaration of The German AIDS-society (DAIG), The Austrian AIDS-society (OEAG) as well as The Robert-Koch Institute Berlin (RKI), The German Association of Physicians specialized in HIV Care (DAGNAE), The German Society of Pediatric and Youth Medicine (DGKJ), The German AIDS Pediatric Association (PAAD), The German Society of Obstetrics and Gynecology (DGGG), The National Reference Center for Retroviruses (NRZ), German AIDS Assistance (DAH).
Buchholz B; Marcus U; Beichert M; Grubert T; Gingelmaier A; Kaestner R; Grosch-Woerner I; Brockmeyer NH; ; ; ; ; ; ; ; ;
Eur J Med Res; 2002 Oct; 7(10):417-33. PubMed ID: 12435621
[TBL] [Abstract][Full Text] [Related]
36. Horizontal versus vertical transmission of human immunodeficiency virus type 1 (HIV-1). Experience from southwestern Saudi Arabia.
al-Nozha MM; al-Frayh AR; al-Nasser M; Ramia S
Trop Geogr Med; 1995; 47(6):293-5. PubMed ID: 8650743
[TBL] [Abstract][Full Text] [Related]
37. German-Austrian Guidelines for HIV-therapy during pregnancy--status: May/June 1998--common statement of the Deutsche AIDS-Gesellschaft (DAIG) and the Osterreichische AIDS-Gesellschaft (OAG).
Brockmeyer N
Eur J Med Res; 1999 Jan; 4(1):35-42. PubMed ID: 9892574
[TBL] [Abstract][Full Text] [Related]
38. Pregnancy in HIV-infected women. Counseling and care--12 years' experiences and results.
Lindgren S; Ottenblad C; Bengtsson AB; Bohlin AB
Acta Obstet Gynecol Scand; 1998 May; 77(5):532-41. PubMed ID: 9654176
[TBL] [Abstract][Full Text] [Related]
39. Preventing perinatal human immunodeficiency virus transmission: factors influencing women's intentions toward zidovudine therapy.
Sowell RL; Murdaugh CL; Addy C; Moneyham L; Tavokoli A; Misener T
South Med J; 2001 Dec; 94(12):1177-84. PubMed ID: 11811856
[TBL] [Abstract][Full Text] [Related]
40. Voluntary counselling and testing (VCT) uptake, nevirapine use and infant feeding options at the University of Nigeria Teaching Hospital.
Onah HE; Ibeziako N; Nkwo PO; Obi SN; Nwankwo TO
J Obstet Gynaecol; 2008 Apr; 28(3):276-9. PubMed ID: 18569467
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
